Now Available: IDS-iSYS 17-OH Progesterone Assay
We are pleased to announce the launch of the IDS-iSYS 17-OH Progesterone assay in the European market – a fully automated assay for use with the IDS-iSYS Multi-Discipline Automated System.
The launch of the IDS-iSYS 17-OH Progesterone assay is the first product released as part of the upcoming fertility (steroid hormones) portfolio.
The IDS-iSYS 17-OH Progesterone assay measures a patient’s 17-OH Progesterone level and offers clinicians an easy, non-invasive way to diagnose disorders of the adrenal gland or the ovaries, such as Congenital Adrenal Hyperplasia (CAH) or Polycystic Ovarian Syndrome (PCOS). Women with PCOS will have higher than normal levels of 17-OH Progesterone which can be a cause of infertility in women.
The steroid 17 Hydroxyprogesterone (17-OH P) is produced by both the adrenal cortex and gonads. It is synthesised from progesterone and serves primarily as a precursor compound that is converted into cortisol in the adrenal gland, or into androgenic and estrogenic steroid hormones in the gonads. 17-OH P is routinely used for the diagnostic assessment of 21-hydroxylase deficiency, which is linked to congenital adrenal hyperplasia.
In adult non-pregnant women, 17-OH P levels in the blood depend on the phase of the menstrual cycle. Like progesterone, 17-OH P is secreted by the mature follicle and the corpus luteum. Concentrations are generally higher after ovulation.
As the only fully automated solution, the IDS-iSYS 17-OH Progesterone assay allows laboratories to benefit from reduced time to first result for measurement of patient samples.